Chris Silvin

481 total citations
4 papers, 405 citations indexed

About

Chris Silvin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Chris Silvin has authored 4 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Chris Silvin's work include Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune cells in cancer (2 papers). Chris Silvin is often cited by papers focused on Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune cells in cancer (2 papers). Chris Silvin collaborates with scholars based in United States, Germany and Canada. Chris Silvin's co-authors include Clint Allen, Paúl E. Clavijo, Jay Friedman, Carter Van Waes, Harrison Cash, Ruth J. Davis, Ellen Moore, Zhong Chen, Jeffrey Schlom and Yvette Robbins and has published in prestigious journals such as Cancer Research, Advances in experimental medicine and biology and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Chris Silvin

4 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Silvin United States	4	323	290	71	30	26	4	405
Sarah Greene United States	5	393 1.2×	370 1.3×	81 1.1×	34 1.1×	40 1.5×	5	516
Jessica Waibl Polania United States	7	202 0.6×	178 0.6×	85 1.2×	22 0.7×	23 0.9×	12	331
Carla Costa-Nunes Switzerland	3	368 1.1×	381 1.3×	87 1.2×	13 0.4×	44 1.7×	3	483
Debbie Strachan United States	3	272 0.8×	192 0.7×	105 1.5×	29 1.0×	23 0.9×	6	361
Janet Lau United States	5	199 0.6×	259 0.9×	76 1.1×	35 1.2×	37 1.4×	8	367
Kathrin Meinhardt Germany	5	241 0.7×	207 0.7×	119 1.7×	12 0.4×	33 1.3×	8	377
Marius Messemaker Switzerland	3	354 1.1×	216 0.7×	107 1.5×	51 1.7×	33 1.3×	3	460
Stephen R. Goding United States	9	236 0.7×	211 0.7×	39 0.5×	10 0.3×	18 0.7×	10	319
Kayla McCarty United States	3	204 0.6×	276 1.0×	73 1.0×	19 0.6×	35 1.3×	5	339
Chujun Zhao China	6	145 0.4×	145 0.5×	82 1.2×	19 0.6×	48 1.8×	6	279

Countries citing papers authored by Chris Silvin

Since Specialization

Citations

This map shows the geographic impact of Chris Silvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Silvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Silvin more than expected).

Fields of papers citing papers by Chris Silvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Silvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Silvin. The network helps show where Chris Silvin may publish in the future.

Co-authorship network of co-authors of Chris Silvin

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Silvin. A scholar is included among the top collaborators of Chris Silvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Silvin. Chris Silvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Lee, Maxwell, Yvette Robbins, Cem Sievers, et al.. (2021). Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells. Journal for ImmunoTherapy of Cancer. 9(3). e002128–e002128. 34 indexed citations

2.

Sun, Lillian, Paúl E. Clavijo, Yvette Robbins, et al.. (2019). Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 4(7). 188 indexed citations

3.

Davis, Ruth J., Ellen Moore, Paúl E. Clavijo, et al.. (2017). Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. Cancer Research. 77(10). 2607–2619. 178 indexed citations

4.

Zein, Wadih M., et al.. (2011). Serum Biomarkers and Trafficking Defects in Peripheral Tissues Reflect the Severity of Retinopathy in Three Brothers Affected by Choroideremia. Advances in experimental medicine and biology. 723. 381–387. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact